Truist Financial raised its target price and Amundi increased its position in Harmony Biosciences shares.
2 reports, 2 independent
Updated Mon 00:00
No new developments lately
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its target price and Amundi increased its position in Harmony Biosciences shares.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Truist Financial raised its price target for Harmony Biosciences.1 source
Truist raised target price and Amundi increased stake in Harmony Biosciences.1 source
Keep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
Amundi
French subsidiary jointly created by Crédit Agricole and Société Générale
Related events
- Amundi increased its stock holdings in Apple Inc. on October 20, 2026.
- Amundi raised its holdings in Mastercard stock on October 31, 2026.
- Amundi increased its stock holdings in Spotify Technology on October 24, 2026.
- Amundi raised its holdings in Microsoft shares on October 16, 2026.
- Amundi increased its investment stake in Alphabet Inc. shares.